Envision Healthcare Co. (EVHC) Position Decreased by KBC Group NV

KBC Group NV decreased its stake in Envision Healthcare Co. (NYSE:EVHC) by 68.7% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 27,585 shares of the company’s stock after selling 60,435 shares during the quarter. KBC Group NV’s holdings in Envision Healthcare were worth $1,240,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also made changes to their positions in EVHC. Commonwealth Bank of Australia lifted its holdings in shares of Envision Healthcare by 24.3% during the 2nd quarter. Commonwealth Bank of Australia now owns 2,096 shares of the company’s stock valued at $130,000 after buying an additional 410 shares during the last quarter. LMR Partners LLP bought a new stake in Envision Healthcare in the second quarter valued at about $205,000. Cutter & CO Brokerage Inc. increased its holdings in Envision Healthcare by 11.1% in the second quarter. Cutter & CO Brokerage Inc. now owns 3,668 shares of the company’s stock valued at $230,000 after purchasing an additional 367 shares during the last quarter. Flinton Capital Management LLC increased its holdings in Envision Healthcare by 18.7% in the second quarter. Flinton Capital Management LLC now owns 4,464 shares of the company’s stock valued at $280,000 after purchasing an additional 704 shares during the last quarter. Finally, D.A. Davidson & CO. increased its holdings in shares of Envision Healthcare by 30.0% in the second quarter. D.A. Davidson & CO. now owns 4,589 shares of the company’s stock worth $287,000 after acquiring an additional 1,059 shares in the last quarter.

Shares of Envision Healthcare Co. (EVHC) traded down $0.03 during midday trading on Thursday, reaching $33.37. The company had a trading volume of 4,039,400 shares, compared to its average volume of 2,267,143. Envision Healthcare Co. has a 1 year low of $23.77 and a 1 year high of $73.00. The company has a quick ratio of 3.00, a current ratio of 3.01 and a debt-to-equity ratio of 0.89. The firm has a market capitalization of $4,037.10, a PE ratio of 10.31, a PEG ratio of 0.87 and a beta of 0.57.

Envision Healthcare (NYSE:EVHC) last issued its quarterly earnings results on Tuesday, October 31st. The company reported $0.73 EPS for the quarter, missing the consensus estimate of $0.81 by ($0.08). Envision Healthcare had a negative net margin of 6.39% and a positive return on equity of 4.88%. The company had revenue of $1.99 billion for the quarter, compared to analyst estimates of $2.03 billion. During the same period last year, the company posted $1.13 earnings per share. The business’s revenue for the quarter was up 142.0% on a year-over-year basis. sell-side analysts forecast that Envision Healthcare Co. will post 2.56 earnings per share for the current fiscal year.

Envision Healthcare declared that its Board of Directors has approved a stock repurchase plan on Monday, September 18th that authorizes the company to buyback $250.00 million in shares. This buyback authorization authorizes the company to purchase up to 4.5% of its shares through open market purchases. Shares buyback plans are usually a sign that the company’s board believes its stock is undervalued.

Several brokerages have issued reports on EVHC. Piper Jaffray Companies began coverage on Envision Healthcare in a report on Wednesday. They issued a “neutral” rating and a $35.00 price target for the company. Credit Suisse Group began coverage on Envision Healthcare in a report on Monday. They issued an “outperform” rating and a $36.00 price target for the company. Mizuho set a $31.00 price target on Envision Healthcare and gave the stock a “neutral” rating in a report on Friday, November 17th. Robert W. Baird set a $35.00 price target on Envision Healthcare and gave the stock a “buy” rating in a report on Tuesday, November 14th. Finally, Cantor Fitzgerald restated a “hold” rating and issued a $30.00 price target on shares of Envision Healthcare in a report on Tuesday, November 14th. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the stock. The stock presently has an average rating of “Buy” and an average price target of $46.06.

ILLEGAL ACTIVITY WARNING: This article was reported by The Lincolnian Online and is the property of of The Lincolnian Online. If you are reading this article on another domain, it was copied illegally and republished in violation of United States and international trademark and copyright law. The correct version of this article can be read at https://www.thelincolnianonline.com/2017/12/14/envision-healthcare-co-evhc-position-decreased-by-kbc-group-nv.html.

Envision Healthcare Company Profile

Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.

Want to see what other hedge funds are holding EVHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Envision Healthcare Co. (NYSE:EVHC).

Institutional Ownership by Quarter for Envision Healthcare (NYSE:EVHC)

Receive News & Ratings for Envision Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply